Temporary relief of pain at the time of treatment was recorded in 92% of the patients receiving traction and 86% of those who were positioned without traction.
Langat virus, which was isolated from the tick Ixodes granulatus in Malaya (Smith, 1956) , was mainly used in this study. Human infections with it are rare and no natural disease due to it is known. It was hoped that Langat virus might produce at least a remission in some of the patients with little or no virus-induced illness. If the infections caused only mild symptoms or were asymptomatic this virus would be a candidate live vaccine against the serious illnesses produced by other tick-borne complex viruses. Experiments in monkeys (O'Reilly et al., 1965) have shown that considerable crossprotection can be conferred by a similar strain and passage level of Langat virus against other tick-borne complex viruses (Kyasanur Forest disease, tick-borne encephalitis). Price et al. (1961) showed that one strain of Langat virus (TP-21-9) which had been passaged in chick-embryo-tissue cultures did not produce encephalitis when inoculated intracerebrally into rhesus monkeys and that when three live viruses-yellow fever, West Nile, and Langat (TP-21-9)-were given in series there was subsequent good protection against a wide range of group B arboviruses. Shah et al. (1962) studied Langat virus in mice and guinea-pigs and demonstrated a good measure of protection against some tick-borne complex viruses. Smorodintsev (1963) carried out preliminary trials in man with live Langat virus as a vaccine against Russian spring-summer encephalitis.
Virus was therefore given to patients with various malignant diseases. Most patients were in the late stages of the disorder, many had become refractory to conventional therapy, and the remainder were thought unlikely to respond to such treatment. The nature of the treatment was carefully explained to each of them and to their relatives by one of us and their full consent was obtained. * 
Materials and Methods
Since November 1960 33 patients have been treated. The 28 whose findings are presented fall into two main groups: 10 leukaemic patients and 18 with a variety of other neoplastic processes, of which bronchial carcinoma was the most common (Tables I and II) . The remaining five patients given virus are mentioned only briefly: three given virus orally developed neither viraemia nor antibodies; one died following a myocardial infarction 48 hours after inoculation and no virus was recovered post mortem; one died three hours after inoculation, from respiratory failure, and virus was recovered from the site of inoculation only.
All but one of the patients with leukaemia were receiving, or had been receiving, singly or in combination, chlorambucil, mercaptopurine, and prednisone. Though these drugs could have influenced the course of the virus infection and the development of antibodies they could not have been directly responsible for any observed therapeutic or haematological effects, since, with the exception of Case 8, virus was given only when there was convincing evidence that the drugs were ineffective. All the patients were kept in hospital for at least 28 days or until death.
Virology
Viruses.-Patients were infected with bacteriologically sterile mouse-brain virus diluted in sterile saline containing 0.75% bovine albumin and buffered at pH 7. When the patient was inoculated the virus was simultaneously titrated by intracerebral inoculation of mice 3-4 weeks old. All infectivity titres were calculated by moving averages (Thompson, 1947) . Langat virus (TP-21 strain) was used in its seventh mouse-passage. Four patients were given the TP-77 strain of Langat. Kyasanur Forest disease virus (W3771 CD IV strain) was used in its seventh or eighth mouse-passages. Viraemia and Post-mortem Tissues.-After inoculation blood was taken three times a week for the likely duration of viraemia. Several ampoules of each sample were stored at -700 C. Sera were stored at -20°C. until tested. The blood samples were later inoculated intracerebrally (0.02 ml.) into baby mice (1-4 days old Fulton and Dumbell (1949) Case 12.-A man aged 59 had carcinoma of the bronchus confirmed by biopsy. He was first treated with Langat virus and radiotherapy in July 1961. The combined therapy made assessment of the role of virus in the subsequent improvement impossible. Perhaps because of the radiotherapy, his antibody response to the virus was, in spite of some viraemia, poor and transient. Therefore, when four months later there was such clinical deterioration that his condition was regarded as terminal, he was inoculated with Kyasanur Forest disease virus. From the third to the eleventh day he was febrile, and by the twenty-sixth day his clinical improvement was so striking that he was ambulant and cheerful. By the fortieth day there was further deterioration; he died of bronchopneumonia on the fifty-fifth day. At necropsy there was no macroscopic or microscopical evidence of tumour in the lung. Tumour was present in liver and adrenal and there was active pyelonephritis.
Doubtful Benefit
In three patients it was difficult to attribute to the virus the improvement which followed therapy, either because of other simultaneous treatment or because of the variable nature of the disease itself.
Case 20.-A man of 54 was admitted in April 1961 with a sixweeks history of unsteadiness and a tendency to fall to the right. He was grossly ataxic and almost blind from papilloedema. A biopsy was made of a cerebellar tumour, which was partially removed.
The primary carcinoma in the lung was discovered a few days later. Sixteen days after the biopsy he was given Langat virus. Case 28.-A man aged 41 presented in June 1963 with a solitary myeloma of the sternum, which was treated with radiotherapy. Within six months bone pain returned and x-ray examination showed generalized skeletal deposits of myeloma. He developed severe pain in his thoracic cage, thrombophlebitis of the legs, and pneumonia. After inoculation with Langat virus he gained weight, the pain became much less, his E.S.R. fell, and he returned to work. There was no convincing radiological bone change. Fifteen months after being given virus he had a recurrence of pain in his back and ribs. For this he was given a course of melphalan with benefit, and has continued with this as intermittent therapy. He remained reasonably well two years later.
Case 18.-A man of 59 was admitted in April 1964 complaining of having had severe pain in the left shoulder, right loin, and right leg for eight weeks. There were many skin nodules. Biopsies established the diagnosis of oat-cell carcinoma of the bronchus with multiple skin secondaries. He was given Langat virus and ran a mild pyrexia of 99.-100' F. (37.4-37.8' C.) between the fourth and thirteenth post-inoculation days. No regression of skin nodules resulted, but there was a most striking improvement in his pain. He died on the twenty-sixth day, and necropsy showed very extensive metastatic spread of tumour.
BRrTsH MEDICAL JOURNAL 261 showed no correlation between pre-inoculation count and the lowest post-inoculation count (P>10% (Table II) , as compared with the 8 out of 10 in the leukaemic group. The pattern of fall was essentially the same as that observed in the leukaemic group (Fig. 4) . The lowest counts, which ranged from 42 to 78% of the pre-inoculation level (mean 59%), were found 2 to 24 Oolo Haematological Findings in the Leukaemic Group Of the 10 patients treated three had chronic lymphocytic leukaemia and seven had various forms of acute leukaemia. All except one (Case 3) had at some period received corticosteroids and chemotherapy. All but one of these had become refractory to such treatment and were in clinical and haematological relapse at the time of virus inoculation. This one patient (Case 8), first seen in the terminal stage of chronic lymphocytic leukaemia, was initially treated with chlorambucil, and the haematological changes observed could have been due to the drug, the virus, or both.
Total Leucocyte Count.-Eight of the patients, including six of those with acute leukaemia and Case 8, showed a significant fall in total count following infection (Table I) . The remaining two patients (Cases 7 and 10) showed falls in total leucocyte count in relation to the viraemia, but these were not statistically acceptable (P>10%). The lowest counts, which ranged from 4 to 70% of the pre-inoculation count (mean 27%), were observed 9 to 34 days after inoculation (mean 17 days). Though the most impressive changes were observed in patients with high pre-inoculation leucocyte counts (Figs. 1 and 3 (Fig. 4) In one patient (Case 18) with bronchial carcinoma and multiple skin metastases secondary nodules were biopsied before inoculation, during viraemia (7th day), and after the end of viraemia at 14 and 21 days. Minimal and identical degenerative changes (pyknosis, nuclear disintegration, and necrosis) were found in pre-and post-inoculation tissues. For various BRITISH MEDICAL JOURNAL reasons serial marrow samples were obtained from only a few patients. So far no morphological changes attributable to virus have been seen. Serial marrow chromosome studies were carried out on one patient in this series (Case 18). It will be seen (Table III) that the first post-inoculation sample showed a complete disorganization of chromosomal pattern with, in the later post-inoculation sample, partial reversion to normality. The detailed chromosome findings in this patient and in a subsequent series will be the subject of a further report.
Virological Findings in Infections with Langat Virus Doses and Infections
Twenty-four patients were given subcutaneous doses of 2,000-500,000 mouse ICLD50 of the seventh mouse-passage of the TP-21 strain of Langat virus. All except three of these (Cases 13, 16, and 23) subsequently had viraemia. Case 13 had virus in various organs at necropsy (see Table V ). Case 16 had unexplained pre-existing antibody of all three types, but showed significant antibody increases. Case 23 developed antibodies. There was therefore probably low and transient viraemia in these patients. One patient, a West Indian (Case24), was given 500,000 ICLD50 intravenously but failed to show evidence of infection. She had, however, pre-existing antibody to a number of group B viruses. Two patients, mentioned in the introduction but not included in the series, were given 25 million ICLD50 of the same virus orally, but subsequently showed no evidence of infection. Monkeys have been successfully infected in this way, perhaps through mouth lesions (O'Reilly et al., 1965) .
Because of the occurrence of encephalitis in two patients, less neuropathogenic strains of Langat virus were sought by plaque-passage in chick-embryo-cell cultures (Begum, 1963) . Three patients (Cases 17, 19, and 21) were given 84,000 ICLD50 of the fourth plaque-passage (after one or two subsequent mouse-passages) and all had viraemia. One patient (excluded from this series) given 13,000 ICLD50 of the fifth plaquepassage, however, showed no evidence of infection. Haemagglutinin-inhibiting Antibody.-H.I. antibody appeared earlier in the non-leukaemic group, but higher and more consistent titres were reached in the leukaemic group. In the nonleukaemic group two patients had high titres on the fourteenth day, 50% (5 out of 10) had antibody by the twenty-first day, and 54% (7 out of 13) by the twenty-eighth day. Three further Tumour involvement of the central nervous system might have been responsible for antibody leakage into the C.S.F., but it was difficult to be certain which patients, especially leukaemics, did not have small tumour deposits in the central nervous system. With these reservations three out of five patients with tumour lesions of the central nervous system had C.S.F. antibody compared with one out of eight without. A combination of tumour involvement and time therefore appear to be possible factors.
Post-mortem Tissues
The results in tissues from 11 patients examined are shown in Table V . In one patient (Case 11) who died during viraemia, though virus was generally distributed, there was 1,000 times more in the secondary tumour than elsewhere. In Case 13 virus was found in a variety of tissues, including brain and tumour, though viraemia had not been detected. In three patients whose viraemia had ceased and who had significant Tuor Secondary 3 ____ _ 1___ _____________________________ + = Titre < 0 5 log mouse LD.so/0 03 ml. Titres expressed a! * Viraemia just before death: 2-7. t Pre-infection antibody: neutralizing 1-2, H.I., 10, C.F., 64.
is log mouse LDs5/0-03 ml. L = Leukaemia. neutralizing antibody circulating virus was detected in the tissues: in the central nervous system of two, in the secondary tumour of one, and also in the spleen and adrenal gland. Virus was not detected in the patients dying 44 and 73 days after infection.
Virological Findings in Infections with Kyasanur
Forest Disease Virus Three patients were infected: Case 3 was given 7,000 mouse ICLD5 , and Cases 12 and 20, who had previously (143 and 173 days respectively) been infected with Langat virus, were given 14 and 85,000 ICLDa respectively. Prior to infection the Langat antibody pictures of these two were as follows: Case 12 had had only a transient neutralizing antibody response and had no detectable antibody when reinfected; Case 20, log neutralizing index 3.3, H.I. 1/10, C.F. 1/4.
Viracmia.-Case 3 had viraemia from the 5th to the 17th post-inoculation day, with a maximum titre of 10 million ICLD,5/0.03 ml. and titres over 10 million ICLD5,/0.03 ml.
from the 7th to the 10th day. Case 12 had viraemia from the 5th to the 14th day, which never exceeded 500 ICLD,0/0.03 ml. Case 20 had a trace of viraemia on the 2nd day only. Though a very low viraemia occurred in the presence of Langat antibody (Case 20) (1949, 1951 ) demonstrated some oncolytic effect on mouse sarcomas by viruses in the same tick-borne complex as Langat virus. Southam and Moore (1951, 1952) showed that other arboviruses-Ilheus, West Nine, and Bunyamwera-have some oncolytic effect on reticuloses and neoplastic disease. Remissions in human leukaemia have occasionally been observed to follow virus diseases (Dock, 1904 ; Pelner et al., 1958) , and recently Wheelock and Dingle (1964) described remissions but no permanent cure in a case of myeloid leukaemia in which they administered a series of virus infections.
(b) A wide variety of neoplastic diseases of fowls and rodents are known to be caused by viruses (Southam, 1963; Porter, 1963; Andrews, 1964) . Though no human neoplastic disease has been shown to have a viral aetiology, two human adenoviruses have been found to cause tumours in hamsters and mice (Huebner et al., 1963 ; Yabe et al., 1964) . Malignant transformation of hamster cells has been induced by polyoma and SV40 viruses, and polyoma virus will also transform (Shein and Enders, 1962; Black and Rowe, 1963 ; Habel, 1963 (Zilber, 1962) and the tumour then becomes virusfree, as do those caused by adenoviruses, papovaviruses, and Rous sarcoma virus (Huebner et al., 1963) , interference seems unlikely to be an effective mechanism. (c) There is, as yet, little evidence on which to discuss the third possible mechanism, but virus-induced tumours and virus-transformed cells carry virus-specific antigens (Habel, 1962) which might act in this way. The chromosomal changes seen in Case 18 suggest that such alterations may occur, and similar changes in chromosomal pattern have been reported during other infectious diseases (Nichols et al., 1962; Aula 1964; Harnden, 1964; Wiedemann, 1964; Massimo et al., 1965) . When oncolysis was induced by virus infection in transplantable tumours of mice, the mice subsequently had a solid immunity to reimplantation of the same tumour (Koprowski et al., 1957; Lindenmann, 1963) and even to some other tumours (Lindenmann and Klein, 1965) .
In none of our cases has there been any question of a patient being cured, but the results are sufficiently encouraging to justify continuation of the attempts. The patients treated were at a terminal stage of their disease, but many of those with leukaemia had a dramatic fall in white-cell count, in one patient (Case 6) associated with diminution in the size of the spleen and lymph nodes and in another (Case 3) with the regression of leukaemia skin lesions and settling of the temperature. If in these two patients the secondary infection and the thrombocytopenia could have been anticipated and controlled a significant remission might have occurred. It may be relevant that tick-borne fever in lambs, which is associated with severe leucopenia, increases their susceptibility to staphylococcal infection a hundredfold (Foggie, 1962) . The haematological findings reported here suggest that the duration of virusinduced leucopenia may be limited by the development of antibodies. Therapeutic effect, particularly in leukaemia, might therefore be enhanced by suppression of antibody formation.
Of the patients with malignant disease other than leukaemia several showed possible evidence of specific effects on tumours by the virus: the disappearance of the secondary skull tumours of Case 21; the high virus titres in the primary tumour of A considerable number of patients showed significant haematological changes. Chromosomal changes were found in the one patient studied.
Though this approach still has considerable therapeutic limitations, the present findings suggest that it merits further study.
Infective drug resistance is now known to be important in the spread of drug resistance among members of the Enterobacteriaceae. It has been studied extensively in Japan, where it was first discovered in 1959; the results have been reviewed by Watanabe (1963) . By comparison little has been published in other countries. Observations on the situation in Britain have been made by Datta (1962) , Anderson and Datta (1965) , and Anderson and Lewis (1965) . These have dealt mainly with Salmonella typhimurium.
It was felt that an impression of the importance of infective resistance as a cause of drug resistance in the Enterobacteriaceae in Britain might be obtained by assessing its incidence in Escherichia coli, since these organisms form the bulk of the enterobacteriaceal flora of the alimentary tract of man and domestic animals. The results of such a survey are reported in this paper. So are studies involving the transfer, in vitro, of resistance from non-pathogenic E. coli isolated from the faeces of man, calves, pigs, and fowls to some of the principal Salmonella and E. coli serotypes that cause disease in these species. The experiments included the use, as donors, of E. coli that were tetracycline-resistant only, organisms that are often found in the faeces of pigs and fowls fed diets containing tetracyclines (Smith and Crabb, 1957) . The results of transferring resistance among Salmonella serotypes and from them to pathogenic serotypes of E. coli are also described.
Methods

Transfer of Resistance
Nutrient broth (Oxoid No. 2) in 10-ml. amounts was seeded with 0.02 ml. of a 24-hour broth culture of the "donor" strain and 0.1 ml. of a similar culture of the "recipient" strain. The mixed culture was incubated at 370 C. for 24 hours and centrifuged. The deposit was inoculated heavily on to a Petri plate of solid medium containing a drug to which the donor was resistant and the recipient was initially sensitive (referred to as selection medium). The plate was then incubated at 37' C. for 24 hours and examined for colonies of the recipient strain. If any were found a few were picked, purified by plating on solid medium, and a single colony was then picked into broth and the drug resistance pattern of the resulting culture determined. Controls consisting of broth that had been inoculated with the recipient culture only were always kept.
When the recipient was a Salmonella sp., deoxycholate citrate agar was used as the basal selection medium, the inoculum sometimes first being incubated in selenite F medium at 370 C. for 18 hours in the hope of suppressing the E. coli if they were of the kind that multiplied on deoxycholate citrate agar. When the recipient was E. coli, MacConkey agar was employed as the basal selection medium, except when the donor was also a strain of E. coli. In the latter event nutrient agar containing washed erythrocytes was used if either donor or recipient was haemolytic. When both were non-haemolytic differentiation was usually an impossible task. When the donor was streptomycin-sensitive the situation was overcome by preparing a chromosome mutant from the recipient that was streptomycin-resistant and incorporating streptomycin as an additional drug in the selection medium. On a few occasions a strain of E. coli naturally resistant to furazolidone only was used in a similar manner, the additional drug added to the basal selection medium in this case being furazolidone. Normally the drug employed in the selection medium was streptomycin yug./ml.), oxytetracycline (20-40 pg./ml.), chloramphenicol (20 pxg./ml.), ampicillin (20-30 ug./ml.), neomycin (20 /Ag./ml.), or furazolidone (10-20 pg./ml.).
Sensitivity Tests
Approximately 0.15 ml. of a 1 in 50 dilution of a 24-hour broth culture of the strain to be tested was spread evenly over the surface of a dried Petri plate of MacConkey agar, and disks containing different drugs were then applied at approximately equal distances apart. The amounts of the drugs used were 50 /Ag. of streptomycin (S), oxytetracycline (T), chlortetracycline (T), chloramphenicol (C), and neomycin (N), and 25 j'g. of ampicillin (A) and furazolidone (F), and 150 ug. of sulphadimidine (Su). The plates were incubated at 37°C. for 24 hours and read. Except in the case 9f sulphadimidine no difficulty was experienced in making the readings; the zones of inhibition surrounding the disks were either wide or very narrow or non-existent. All cultures that appeared to be sulphadimidine-resistant were retested on nutrient agar in which sulphonamide inhibitors had been neutralized by the addition of lysed horse * Animal Health Trust, Stock, Essex.
